Profile	GDS4460 / 212751_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	341.1	86
GSM803589	patient 7, baseline	330	85
GSM803592	patient 8, baseline	322.6	85
GSM803595	patient 10, baseline	239.6	81
GSM803598	patient 11, baseline	307.5	85
GSM803601	patient 12, baseline	283.4	83
GSM803604	patient 13, baseline	360.6	87
GSM803607	patient 14, baseline	410.3	88
GSM803610	patient 15, baseline	298.8	84
GSM803613	patient 16, baseline	445.9	89
GSM803587	patient 6, arm treated with pimecrolimus	357.2	87
GSM803590	patient 7, arm treated with pimecrolimus	353.9	86
GSM803593	patient 8, arm treated with pimecrolimus	241	81
GSM803605	patient 13, arm treated with pimecrolimus	307	85
GSM803608	patient 14, arm treated with pimecrolimus	421.6	88
GSM803599	patient 11, arm treated with pimecrolimus	375.2	87
GSM803611	patient 15, arm treated with pimecrolimus	356.6	86
GSM803614	patient 16, arm treated with pimecrolimus	371.1	87
GSM803602	patient 12, arm treated with pimecrolimus	340.1	86
GSM803596	patient 10, arm treated with pimecrolimus	238	81
GSM803591	patient 8, arm treated with betamethasone	387.7	87
GSM803609	patient 15, arm treated with betamethasone	212.2	79
GSM803597	patient 11, arm treated with betamethasone	339.4	86
GSM803585	patient 6, arm treated with betamethasone	291	84
GSM803603	patient 13, arm treated with betamethasone	266	83
GSM803612	patient 16, arm treated with betamethasone	310.3	84
GSM803588	patient 7, arm treated with betamethasone	291.7	84
GSM803594	patient 10, arm treated with betamethasone	278.5	83
GSM803600	patient 12, arm treated with betamethasone	272.5	83
GSM803606	patient 14, arm treated with betamethasone	337.3	86